11 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... Society of America #HFrEF ... HeartFailure #Management #CHF ... #treatment #algorithm ... #sCHF
Treatment options for patients with Chronic Symptomatic Systolic Heart Failure

#sCHF #CongestiveHeartFailure #Systolic #HFrEF #Algorithm #Management #Cardiology
Treatment options ... Symptomatic Systolic Heart ... CongestiveHeartFailure #Systolic #HFrEF ... #Algorithm #Management ... #Medications
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
Algorithm for screening ... /diagnosis and treatment ... #sCHF #HeartFailure ... #Cardiology #Indications ... #Treatment
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Deficiency in Heart ... Algorithm Diagnosis ... Guidelines: • ACC ... iron #deficiency #CHF ... #cardiology #treatment
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... ) Treatment - GDMT ... patients with Heart ... recommended by the ACC ... #HFrEF #Pharmacology
Heart Failure Medications Summary
Inhibitors of the Renin-Angiotensin System:
 • ACE Inhibitors: Benazepril, Captopril, Enalapril, Lisinopril, Quinapril,
Heart Failure Medications ... Renin-Angiotensin System: • ACE ... #Failure #Medications ... #CHF #cardiology ... #pharmacology
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
milrinone) for HFrEF ... Revascularization, treatment ... NSAlDs, ACE-inhibitors ... #Checklist #CHF ... #HeartFailure #Cardiology
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Heart failure with ... Ejection Fraction (HFrEF ... endomyocardial biopsy Pharmacology ... : • ACE Inhibitors ... #pharmacology #
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
disease b) CHF ... dependent DM ACS ... event, follow ACC ... indication of AC ... • <12mo since ACS
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
cardiomyopathy • Pulmonary ... May have typical HF ... • Avoid ARB/ACE-I ... GDMT meds (e.g., ACE ... #treatment